HbA1c变异性与2型糖尿病患者视网膜病变关系的研究进展

徐子岚 ,  杨琼 ,  黄峥 ,  戴霞

国际老年医学杂志 ›› 2025, Vol. 46 ›› Issue (05) : 614 -618.

PDF (948KB)
国际老年医学杂志 ›› 2025, Vol. 46 ›› Issue (05) : 614 -618. DOI: 10.3969/j.issn.1674-7593.2025.05.019
综述

HbA1c变异性与2型糖尿病患者视网膜病变关系的研究进展

作者信息 +

Recent advances in understanding the relationship between HbA1c variability and diabetic retinopathy in type 2 diabetes mellitus

Author information +
文章历史 +
PDF (970K)

摘要

糖尿病视网膜病变 (DR) 是糖尿病微血管并发症最常见的一种类型, 也是导致成人视力受损和失明的最常见、最重要的原因之一。糖化血红蛋白 (HbA1c) 变异性是反映长期血糖变异性的最常见衡量指标。近年来, 越来越多研究发现 HbA1c 变异性与糖尿病微血管并发症有关, 对 2 型糖尿病患者 DR 的发生发展也有影响。本文对 HbA1c 变异性与 2 型糖尿病患者 DR 的关系与潜在发病机制进行综述, 为 2 型糖尿病 DR 患者的临床治疗及预后改善提供参考。

Abstract

Diabetic retinopathy (DR) is the most common type of diabetic microvascular complications and one of the most common and important causes of visual impairment and blindness in adults. Glycosylated hemoglobin (HbA1c) variability is the most commonly used indicator to reflect long-term glycemic variability. In recent years, an increasing number of studies have found that HbA1c variability is associated with diabetic microvascular complications and also has an impact on the development of DR in patients with type 2 diabetes mellitus. Therefore, this article reviews the relationship and potential pathogenesis between HbA1c variability and DR in patients with type 2 diabetes mellitus to provide a reference for clinical treatment and prognosis improvement of DR in patients with type 2 diabetes mellitus.

关键词

糖化血红蛋白变异性 / 2型糖尿病 / 视网膜病变 / 发病机制

Key words

HbA1c variability / Type 2 diabetes mellitus / Retinopathy / Pathogenesis

引用本文

引用格式 ▾
徐子岚,杨琼,黄峥,戴霞. HbA1c变异性与2型糖尿病患者视网膜病变关系的研究进展[J]. 国际老年医学杂志, 2025, 46(05): 614-618 DOI:10.3969/j.issn.1674-7593.2025.05.019

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Magliano D J, Boyko E J , IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes atlas[M]. 10th ed. Brussels: International Diabetes Federation, 2021.

[2]

Valle M S, Russo C, Malaguarnera L . Protective role of vitamin D against oxidative stress in diabetic retinopathy[J]. Diabetes Metab Res Rev, 2021, 37(8): e3447.

[3]

徐坤, 王俊, 刘光耀, . 2型糖尿病血糖波动与认知功能障碍关系的MRI研究进展[J]. 磁共振成像, 2023, 14(10): 137—140, 146.

[4]

Xu K, Wang J, Liu G Y, et al. Research progress of MRI on the relationship between blood glucose fluctuations and cognitive dysfunction in type 2 diabetes[J]. Chin J Magn Reson Imaging, 2023, 14(10): 137—140, 146.

[5]

陈雪, 周倩倩, 徐慧君 . 糖化血红蛋白变异性对2型糖尿病肾病的影响[J]. 中华糖尿病杂志, 2020, 12(12): 993-998.

[6]

Chen X, Zhou Q Q, Xu H J, et al. Effect of glycated hemoglobin A1c variability on diabetic kidney disease in type 2 diabetes mellitus patients[J]. Chin J Diabetes Mellitus, 2020, 12(12): 993-998.

[7]

Kim H U, Park S P, Kim Y K . Long—term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes[J]. Sci Rep, 2021, 11(1): 4731.

[8]

Hu J, Hsu H C, Yuan X D, et al. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes[J]. J Endocrinol Invest, 2021, 44(6): 1229-1236.

[9]

Tseng J Y, Chen H H, Huang K C, et al. Effect of mean HbA1c on the association of HbA1c variability and all—cause mortality in patients with type 2 diabetes[J]. Diabetes Obes Metab, 2020, 22(4): 680-687.

[10]

Li S, Nemeth I, Donnelly L, et al. Visit—to—visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes[J]. Diabetes Care, 2020, 43(2): 426-432.

[11]

胡佳琪, 周倩倩, 徐慧君, . HbA1c变异性对糖尿病视网膜病变的影响及其截断值的判定[J]. 眼科新进展, 2020, 40(10): 967-971.

[12]

Hu J Q, Zhou Q Q, Xu H J, et al. Effect of HbA1c variability on diabetic retinopathy and its cut—off value for early diabetic retinopathy diagnosis[J]. Recent Adv Ophthalmol, 2020, 40(10): 967-971.

[13]

缪康琪, 王天天, 张云飞, . 糖化血红蛋白变异性对2型糖尿病视网膜病变的影响及其最佳临界值的确定[J]. 河南医学研究, 2022, 31(14): 2512-2517.

[14]

Miu K Q, Wang T T, Zhang Y F, et al. Effect of glycosylated hemoglobin variability on type 2 diabetic mellitus retinopathy and determination of the optimal critical value[J]. Henan Med Res, 2022, 31(14): 2512-2517.

[15]

Noyes J D, Soto—Pedre E, Donnelly L A, et al. Characteristics of people with high visit—to—visit glycaemic variability in type 2 diabetes[J]. Diabet Med, 2018, 35(2): 262-269.

[16]

Vural Keskinler M, Takir M, Caklili O T, et al. The frequency and determinants of HbA1c variability in type 2 diabetic patients[J]. Metab Syndr Relat Disord, 2021, 19(7): 372-377.

[17]

刘欢, 莫永珍, 唐伟, . 老年2型糖尿病患者HbA1c变异性的影响因素分析[J]. 医药高职教育与现代护理, 2022, 5(2): 93-97.

[18]

Liu H, Mo Y Z, Tang Wei, et al. Analysis of influencing factors of HbA1c variability in elderly patients with type 2 diabetes[J]. Med Higher Vocat Educ Mod Nurs, 2022, 5(2): 93-97.

[19]

Sakai R, Hashimoto Y, Hamaguchi M, et al. Living alone is associated with visit—to—visit HbA1c variability in men but not in women in people with type 2 diabetes: KAMOGAWA—DM cohort study[J]. Endocr J, 2020, 67(4): 419-426.

[20]

Kilpatrick E S, Rigby A S, Atkin S L . A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial[J]. Diabetes Care, 2008, 31(11): 2198-2202.

[21]

Watanabe H, Takahara M, Katakami N, et al. Changes of HbA1c variability after the switch to a longer—acting insulin analog in people with type 1 diabetes[J]. J Diabetes Investig, 2023, 14(2): 259-262.

[22]

Mao Y, Zhong W . HbA1c variability as an independent risk factor for microvascular complications in type 1 diabetes[J]. J Diabetes Sci Technol, 2024, 18(2): 380-388.

[23]

Sachdeva M M . Retinal neurodegeneration in diabetes: an emerging concept in diabetic retinopathy[J]. Curr Diab Rep, 2021, 21(12): 65.

[24]

黎晓新 . 《我国糖尿病视网膜病变临床诊疗指南(2022年)———基于循证医学修订》更新点[J]. 中华眼底病杂志, 2023, 39(2): 91-94.

[25]

Li X X. Keypoints in evidence—based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)[J]. Chin J Ocular Fundus Dis, 2023, 39(2): 91-94.

[26]

Foo V, Quah J, Cheung G, et al. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics[J]. J Diabetes, 2017, 9(2): 200-207.

[27]

Song K H, Jeong J S, Kim M K, et al. Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus[J]. J Diabetes Investig, 2019, 10(3): 745-752.

[28]

Guo K, Zhao Q, Wang M, et al. The scope of HbA1c variability and risk of vascular complications among patients with type 2 diabetes: a systematic review and meta—analysis of prospective studies[J]. Horm Metab Res, 2022, 54(2): 94-103.

[29]

Takao T, Suka M, Yanagisawa H, et al. Predictive ability of visit—to—visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes[J]. Diabetes Res Clin Pract, 2017, 128: 15-23.

[30]

Cardoso C R L, Leite N C, Moram C B M, et al. Long—term visit—to—visit glycemic variability as predictor of micro— and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study[J]. Cardiovasc Diabetol, 2018, 17(1): 33.

[31]

Sartore G, Ragazzi E, Caprino R, et al. Long—term HbA1c variability and macro—/micro—vascular complications in type 2 diabetes mellitus: a meta—analysis update[J]. Acta Diabetol, 2023, 60(6): 721-738.

[32]

Tang L, Xu G T, Zhang J F . Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy[J]. Neural Regen Res, 2023, 18(5): 976-982.

[33]

Hu Z, Fang W, Liu Y, et al. Acute glucose fluctuation promotes RAGE expression via reactive oxygen species—mediated NF—κB activation in rat podocytes[J]. Mol Med Rep, 2021, 23(5). doi: 10mmr.2021.11969.

[34]

Sorkhabi R, Ahoor M H, Ghorbani Haghjo A, et al. Assessment of tear inflammatory cytokines concentration in patients with diabetes with varying severity of involvement[J]. Exp Eye Res, 2022, 224: 109233.

[35]

Kang Q, Yang C . Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications[J]. Redox Biol, 2020, 37: 101799.

[36]

Lahouel A . High sugar consumption for seven days in adult mice increased blood glucose variability, induced an anxiolytic effect and triggered oxidative stress in cerebral cortex[J]. Metab Brain Dis, 2024, 39(5): 731-739.

[37]

Costantino S, Paneni F, Battista R, et al. Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with type 2 diabetes and with target HbA1c levels[J]. Diabetes, 2017, 66(9): 2472-2482.

[38]

Wronka M, Krzemińska J, Młynarska E, et al. The influence of lifestyle and treatment on oxidative stress and inflammation in diabetes[J]. Int J Mol Sci, 2022, 23(24): 15743.

[39]

刘芷谷, 姚斌, 林倍思, . 自我血糖监测中血糖波动指标与平均血糖波动幅度的相关性研究[J]. 中华糖尿病杂志, 2021, 13(5): 476-481.

[40]

Liu Z G, Yao B, Lin B S, et al. Correlation between glycemic variability indices calculated by self—monitoring of blood glucose and mean amplitude of glycemic excursion in patients with type 2 diabetes mellitus[J]. Chin J Diabetes Mellitus, 2021, 13(5): 476-481.

[41]

Li S, Deng J, Sun D, et al. FBXW7 alleviates hyperglycemia—induced endothelial oxidative stress injury via ROS and PARP inhibition[J]. Redox Biol, 2022, 58: 102530.

[42]

Colinet V, Lysy P A . Characterization of post—hypoglycemic hyperglycemia in children and adolescents with type 1 diabetes: the EPHICA Study[J]. Front Endocrinol (Lausanne), 2022, 13: 887976.

[43]

Yao Y, Song Q, Hu C, et al. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes[J]. Cardiovasc Res, 2022, 118(1): 196-211.

[44]

Lin C H, Chang C H, Chuang L M . Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study[J]. J Diabetes Investig, 2021, 12(3): 313-316.

[45]

Kowluru R A, Alka K . Mitochondrial quality control and metabolic memory phenomenon associated with continued progression of diabetic retinopathy[J]. Int J Mol Sci, 2023, 24(9): 8076.

[46]

林婧格, 白洁 . 血糖变异性对糖尿病慢性并发症影响及机制的研究进展[J]. 中国糖尿病杂志, 2023, 31(7): 547-550.

[47]

Lin J G, Bai J. Research progress on the effect and mechanism of glucose variability on chronic complications of diabetes mellitus[J]. Chin J Diabetes, 2023, 31(7): 547-550.

[48]

Natarajan R . Epigenetic mechanisms in diabetic vascular complications and metabolic memory: the 2020 Edwin Bierman Award Lecture[J]. Diabetes, 2021, 70(2): 328-337.

基金资助

*国家自然科学基金项目(82160440)

广西自然科学基金(2022JJA141061)

AI Summary AI Mindmap
PDF (948KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/